Abbott Launches New FreeStyle Libre 3 Plus Glucose Sensor in Canada

Abbott has launched its latest generation sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, in Canada. This innovative product features the world's smallest glucose sensor, providing a user-friendly way for Canadians living with diabetes to manage their condition.

Glucose monitoring plays a crucial role in diabetes management, helping individuals understand how their body responds to various factors. Abbott's FreeStyle Libre systems eliminate the need for routine finger pricks by measuring glucose levels through a small sensor worn on the upper arm. The sensor sends data to a smartphone app, enabling real-time tracking and personalized diabetes management.

Healthcare professionals, like Dr. Akshay Jain, recognize the practical benefits of Abbott's latest sensor in simplifying glucose monitoring. With nearly 12 million Canadians living with diabetes, the FreeStyle Libre systems provide valuable insights into managing the condition effectively.

Abbott's commitment to advancing diabetes care is evident through its innovative technologies, such as the FreeStyle Libre 3 Plus* sensor. This compact and user-friendly device empowers individuals to confidently manage their health and make informed decisions about their diabetes.

To learn more about Abbott's FreeStyle Libre 3 Plus* sensor, visit myfreestyle.ca.

According to the source: PR Newswire Canada.